CANCER 2026 Brett Hollier
Queensland University of Technology, QLD, Australia
Presentations this author is a contributor to:
Testing the efficacy of Neuropilin-1 inhibition in pre-clinical models of claudin-low breast cancer (#248)
5:35 PM
Samar Sanjabi
Poster Session 2
Suppressing vasculogenic mimicry in claudin-low breast cancer by targeting Neuropilin-1 (#229)
5:35 PM
Ngoc Minh Long Nguyen
Poster Session 2